Despite the very limited preclinical and clinical data, the ghrelin system seems to be a quite interesting potential target for further studies, and use of an inverse ghrelin receptor antagonist has shown promising preliminary results in the treatment of alcohol use disorder. The gene discussed is GHRL; the disease is alcohol abuse.